Based on the hospital electronic medical record database,to discuss the treatment outcome of the ischemic cerebrovascular disease with Maixuekang capsule,find out the effects of Maixuekang capsule on the treatment outcome of ischemic cerebrovascular disease,and provide reference for clinical rational drug use.Methods:This study was based on the database of electronic medical records of 20 large-scale tertiary-level hospitals across the country,and 1:1 matching of patients with ischemic cerebrovascular disease who used and not used Maixuekang capsules according to certain standards.Recombination of treatment outcomes in the database with “recovery” and “improvement” were defined as treatment effectiveness,“invalidity”“death”,and “other” were merged into treatment-ineffective populations.The efficacy of the group's treatment outcomes was compared by propensity scores.Results:After matching,A group included 2449 cases treated with Maixuekang capsule and B group also included 2449 cases treated with Maixuekang capsule.The simple chi-square test results showed that the effective rate of the two groups had significant statistical difference(P<0.05)in the absence of controlled confounding factors,and the treatment effect of group A was better than that of group B.Three logistic regression analysis methods were used for analysis.All showed that the regression coefficient was greater than 0,and all had statistical significance(P<0.01).Conclusion:Patients with ischemic cerebrovascular disease who used Maixuekang capsules are more effective than that those do not use this drug,and can improve the clinical efficacy of patients with ischemic cerebrovascular disease.